Suchergebnisse - (Subject:"ritonavir")

PubPharm (20)

1

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

enthalten in: HIV clinical trials | 2015

von Young, B. | Squires, K. | Tashima, K. | +6

CommentOn: HIV Clin Trials. 2012 Sep-Oct;13(5):233-44. - PMID 23134624

2

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients

enthalten in: HIV clinical trials | 2014

von Kulkarni, R. | Abram, M. | McColl, D. | +6

3

Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone

enthalten in: HIV clinical trials | 2014

von Wang, Q. | Young, J. | Bernasconi, E. | +60

4

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART

enthalten in: HIV clinical trials | 2013

von Casado, J. | de Los Santos, I. | Del Palacio, M. | +4

5

Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir

enthalten in: HIV clinical trials | 2012

von Gotti, D. | Cesana, B. | Albini, L. | +13

6

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients : SPARTAN study results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +17

7

Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patients

enthalten in: HIV clinical trials | 2011

von Tremblay, C. | Trottier, B. | Rachlis, A. | +5

8

Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir

enthalten in: HIV clinical trials | 2010

von Elion, R. | Berger, D. | Richmond, G. | +14

CommentOn: HIV Clin Trials. 2008 May-Jun;9(3):152-63. - PMID 18547902

9

Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients

enthalten in: HIV clinical trials | 2010

von Squires, K. | Young, B. | DeJesus, E. | +78

10

Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir

enthalten in: HIV clinical trials | 2009

von Rathbun, C. | Liedtke, M. | Blevins, S. | +4